Health FDA Endorses Zepbound for Sleep Apnea SufferersBy Dave Antrobus20 December 2024 The US Food and Drug Administration has given its nod to Zepbound, a weight-loss drug now approved for obstructive sleep…
Health Evaluating Novo Nordisk’s CagriSema in the Weight-Loss Race Against Lilly’s ZepboundBy Sam Allcock20 December 2024 Novo Nordisk has introduced its combination drug, CagriSema, in a recent major trial to challenge Eli Lilly’s Zepbound. This long-standing…
Health Zepbound Outperforms Wegovy in Weight Loss Study, Eli Lilly ReportsBy Sam Allcock4 December 2024 Eli Lilly’s new clinical trial data highlights a significant breakthrough. Adults taking Zepbound, the brand name for tirzepatide, lost nearly…
Health Navigating Life Beyond Weight-Loss MedicationsBy Dave Antrobus16 November 2024 In recent years, GLP-1 medications have become a popular option for adults seeking to manage chronic health conditions and achieve…
Health In-Depth Exploration of Weight Loss MedicationsBy Sam Allcock12 November 2024 In recent years, weight loss drugs have taken centre stage, garnering interest for their dual impact on diabetes and obesity.…
